MusclePharm Corp (MSLP) Major Shareholder Obtained $40,000.00 in Shares

MusclePharm Corp (MSLP) Major Shareholder Obtained $40,000.00 in Shares

MusclePharm Corp (OTCMKTS:MSLP) major shareholder Wynnefield Partners Small Cap bought 100,000 shares of the company’s stock in a transaction dated Thursday, February 7th. The stock was purchased at an average price of $0.40 per share, with a total value of $40,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Wynnefield Partners Small Cap also recently made the following trade(s):

On Monday, December 31st, Wynnefield Partners Small Cap bought 27,925 shares of MusclePharm stock. The stock was purchased at an average price of $0.57 per share, with a total value of $15,917.25.

On Thursday, December 27th, Wynnefield Partners Small Cap bought 2,075 shares of MusclePharm stock. The stock was purchased at an average price of $0.57 per share, with a total value of $1,182.75.

On Wednesday, December 12th, Wynnefield Partners Small Cap bought 60,000 shares of MusclePharm stock. The stock was purchased at an average price of $0.90 per share, with a total value of $54,000.00.

On Friday, November 30th, Wynnefield Partners Small Cap bought 7,000 shares of MusclePharm stock. The stock was purchased at an average price of $0.90 per share, with a total value of $6,300.00.

On Tuesday, November 27th, Wynnefield Partners Small Cap bought 3,000 shares of MusclePharm stock. The stock was purchased at an average price of $0.90 per share, with a total value of $2,700.00.

Shares of OTCMKTS:MSLP opened at $0.56 on Friday. MusclePharm Corp has a 12 month low of $0.30 and a 12 month high of $1.43.

MusclePharm (OTCMKTS:MSLP) last issued its earnings results on Tuesday, November 13th. The company reported ($0.13) EPS for the quarter. The firm had revenue of $27.39 million for the quarter.

About MusclePharm

MusclePharm Corporation develops, manufactures, markets, and distributes nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company's MusclePharm brand product portfolio include Combat protein powder and Combat crunch protein bars; essentials supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products; and non-genetically modified organism sports performance products with organic ingredients, plant-based proteins, and natural caffeine sources for use in the various stages of the workout.

Further Reading: What is the Ex-Dividend Date in Investing?

Related posts

Leave a Comment